CAPSTONE INVESTMENT ADVISORS, LLC - TONIX PHARMACEUTICALS HLDG C ownership

TONIX PHARMACEUTICALS HLDG C's ticker is and the CUSIP is 890260706. A total of 87 filers reported holding TONIX PHARMACEUTICALS HLDG C in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CAPSTONE INVESTMENT ADVISORS, LLC ownership history of TONIX PHARMACEUTICALS HLDG C
ValueSharesWeighting
Q1 2021$73,000
-39.2%
57,031
-67.9%
0.00%
Q4 2020$120,000177,7000.00%
Other shareholders
TONIX PHARMACEUTICALS HLDG C shareholders Q2 2021
NameSharesValueWeighting ↓
GSA CAPITAL PARTNERS LLP 676,761$751,0000.08%
Virtu Financial LLC 294,771$327,0000.03%
MONECO Advisors, LLC 35,000$39,0000.02%
Game Plan Financial Advisors, LLC 22,216$25,0000.02%
Purus Wealth Management, LLC 15,000$17,0000.01%
Renaissance Technologies 7,203,677$7,996,0000.01%
WINTON GROUP Ltd 122,987$137,0000.01%
LINCOLN CAPITAL CORP 10,000$11,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 214,500$238,0000.00%
FIRST MIDWEST BANK TRUST DIVISION 25,000$28,0000.00%
View complete list of TONIX PHARMACEUTICALS HLDG C shareholders